Advertisement

Topics

Alcon Company Profile

18:35 EDT 22nd September 2017 | BioPortfolio

The Alcon group's U.S. headquarters in Fort Worth, Texas, (about 30 miles west of Dallas) is our largest location with over 2,500 employees. We continue to build our team for the future across the United States and worldwide.
We seek dedicated individuals who share our vision of diversified specialization in the field of ophthalmology -- people who are committed to their careers as a means of securing a successful future for themselves while adding value to the world in which they live.

Location

6201 S. Freeway
Fort Worth
76134-2099
United States of America

Contact

Phone: 41+41-785-8888
Email: webmaster@alconlabs.com


News Articles [36 Associated News Articles listed on BioPortfolio]

Novartis CEO reasserts 2018 growth expectations, discusses Alcon and Sandoz future

Novartis has reiterated its expectation of sales growth beginning in 2018, as well as a positive outlook for its Alcon eye care business, according to Chief Executive Joe Jimenez (pictured). Jimenez t...

Novartis-Aktie: Konzern bestätigt Prognose - Alcon läuft etwas besser

Dem Schweizer Pharmakonzern Novartis hat auch im zweiten Quartal die Sanierung des Augenheilgeschäfts Alcon und Generika-Konkurrenz für sein wichtiges Blutkrebsmittel Glivec zu schaffen gemacht. De....

Chief medical officer named by Alcon

Stephen Lane has been tapped to serve as chief medical officer and global head of franchise clinical strategy at Alcon.  -More- 

Novartis CEO Sees Recovery Ahead, Fueled By Pipeline And Alcon Growth

Novartis' half-year results show eye business Alcon and heart drug Entresto - which have been the two main sources of...  

Novartis Quarterly Profit Drops Less Than Analysts Expected

Novartis AG posted a smaller decline in second-quarter profit than analysts had projected amid early signs of a revival at its Alcon eye-care division and as new medicines helped offset the eroding sa...

Alcon names chief medical officer

Stephen S. Lane, MD, will join Alcon as its chief medical officer and global head of franchise clinical strategy, where he will lead the integration of scientific, clinical and commercial priorities a...

Aerie Poaches Another Exec From Novartis AG' Tormented Alcon Biz

  Life Sciences Jobs   ...

Alcon's return to growth gives Novartis 'options', says CEO

Sales up 3% to $1.5bn in second quarter for ailing eyecare division

Drugs and Medications [97 Associated Drugs and Medications listed on BioPortfolio]

Bion tears [Alcon Laboratories, Inc.]

BION® TEARSLUBRICANT EYE DROPS

Systane [Alcon Laboratories, Inc.]

SYSTANE® BALANCE Lubricant Eye Drops

Systane [Alcon Research Ltd]

SystaneLubricant Eye Drops

Systane [Alcon Research Ltd]

Systane ULTRALubricant Eye Drops

Naphcon a®eye drops [ALCON LABORATORIES, INC.]

Naphcon A®Eye Drops

PubMed Articles [6 Associated PubMed Articles listed on BioPortfolio]

Evaluation of Postoperative Astigmatism Correction and Postoperative Rotational Stability of Two Toric Intraocular Lenses.

Background The aim of this retrospective study was to evaluate the rotational stability and the refractive outcome of two different toric IOLs. Methods This study included 41 eyes with corneal astigma...

Comparison of EX-PRESS Shunt and Trabeculectomy With Mitomycin-C in Congenital and Juvenile Glaucoma.

To compare efficacy and safety of EX-PRESS mini glaucoma shunt (Alcon) and trabeculectomy with mitomycin-C (MMC) in the management of pediatric glaucoma.

Prospective Evaluation of Outcomes in Patients Undergoing Treatment for Myopia Using the WaveLight Refractive Suite.

To evaluate outcomes in patients with myopia up to -12.00 diopters (D), with or without astigmatism up to 6.00 D, who underwent LASIK with the WaveLight Refractive Suite (Alcon Laboratories, Inc., For...

Improvement of Phaco Tip Geometry During Torsional Phacoemulsification.

Background Advanced cataract with hard lens nuclei frequently challenge the ophthalmologic surgeon when doing phacoemulsification. In the present study, we examined the effect of a new phaco tip desig...

Manual Removal of Intraocular Lens Silicone Oil Droplets and Dystrophic Calcifications Using a Nitinol Loop: A Case Series.

Deposition of dystrophic calcifications on the posterior surface of silicone intraocular lenses (IOLs) has been reported in patients with asteroid hyalosis. Accumulation of silicone oil droplets on th...

Clinical Trials [24 Associated Clinical Trials listed on BioPortfolio]

Comparison of Functional Vision Provided by AMO Tecnis Z9000 and Alcon SA60AT Acrysof

This study is to compare intraindividually the functional vision provided by two different posterior chamber intraocular lenses: AMO Tecnis Z9000 and Alcon SA60AT Acrysoft. To see if the a...

Evaluation of Disinfecting Solutions and Protein Remover With a Silicone Hydrogel Lens

The purpose of this study is to determine if reduced lens deposits and increased comfort can be achieved by using Multipurpose disinfecting solutions (MPDS) in a no-rub format but in conju...

Prospective Comparative Study of Refractive Outcome of STAAR and Alcon Toric Intraocular Lenses

Several methods have been developed to address and reduce preexisting astigmatism. The refractive results associated with the use of toric IOLs are likely to be more predictable. Other adv...

Tobramycin-Dexamethasone Versus Tobramycin-Dexamethasone Plus Ketorolac After Phacoemulsification Surgery

This randomized controlled trial compares two regimens of topical therapy: - tobramycin 0.3% - dexamethasone 0.1% (TobraDex®, Alcon), one drop four times/day - combination of tobr...

LASIK Using the Alcon Allegretto Wavefront-Guided Excimer Laser vs AMO Visx Wavefront-Guided Excimer Laser

The purpose of the study is to compare the results of LASIK surgery when using Alcon Allegretto wavefront-guided excimer laser system compared to AMO Visx Custom wavefront-guided excimer l...

Companies [9 Associated Companies listed on BioPortfolio]

Alcon, Inc.

Alcon, Inc. is the world’s leading eye care company, with sales of approximately $6.5 billion in 2009. Alcon, which has been dedicated to the ophthalmic industry for 65 years...

Alcon

The Alcon group's U.S. headquarters in Fort Worth, Texas, (about 30 miles west of Dallas) is our largest location with over 2,500 employees. We continue to build our team for the future across the Uni...

StrikeForce Communications LLC

StrikeForce is an award-winning full service agency with a stack of consumer and professional accounts. Clients include both industry giants and specialty companies such as Abbott...

LaVoie Group

LaVoie Group provides senior-level strategic counsel and tactical implementation of strategic communications programs designed to properly position, create visibility and drive value for each client. ...

PanOptica, Inc.

PanOptica, Inc. is a private, venture-backed biopharmaceutical company focused on licensing and developing a portfolio of exciting and innovative therapeutics for major ophthalmic diseases. Since its ...

More Information about "Alcon" on BioPortfolio

We have published hundreds of Alcon news stories on BioPortfolio along with dozens of Alcon Clinical Trials and PubMed Articles about Alcon for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Alcon Companies in our database. You can also find out about relevant Alcon Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record